Jasper Therapeutics, Inc.
JSPR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001788028
No open-market purchases or sales by Jasper Therapeutics, Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $5.05M in total; no superinvestor holds it.
Other share classesJSPRW
Q4 2025 vs. Q3 2025
How the institutions holding Jasper Therapeutics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 60 | 1 | 55 | −4 |
| Shares | 20.2M | 929.0K | 19.2M | −5.64K (0.0%) |
| Value | $47.8M | $2.21M | $35.2M | −$10.4M (−22.9%) |
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Jasper Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ADAR1 Capital Management, LLC | 140,000 | $256.2K | 0.02% |
| Quarry LP | 99,529 | $182.1K | 0.03% |
| Gsa Capital Partners LLP | 74,964 | $137.0K | 0.01% |
| Quadrature Capital Ltd | 67,267 | $123.1K | 0.00% |
| Jacobs Levy Equity Management, Inc | 54,800 | $100.3K | 0.00% |
| Jain Global LLC | 43,301 | $79.2K | 0.00% |
| Panagora Asset Management Inc | 19,362 | $35.4K | 0.00% |
| Engineers Gate Manager LP | 14,257 | $26.1K | 0.00% |
| Jane Street Group, LLC | 10,364 | $19.0K | 0.00% |
| Citigroup Inc | 642 | $1.18K | 0.00% |
| Avion Wealth | 214 | $0 | 0.00% |
Sold out (15)
Institutions that held Jasper Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Kingdon Capital Management, L.L.C. | 1,324,845 | $3.15M |
| Propel Bio Management, LLC | 1,028,806 | $2.45M |
| Simplify Asset Management Inc. | 609,053 | $1.45M |
| Citadel Advisors LLC | 589,449 | $1.40M |
| Armistice Capital, LLC | 348,000 | $828.2K |
| Deutsche Bank AG | 160,000 | $380.8K |
| Bank of Montreal | 111,802 | $266.1K |
| Two Sigma Investments, LP | 40,427 | $96.2K |
| Voleon Capital Management LP | 20,950 | $49.9K |
| Stonepine Capital Management, LLC | 20,200 | $48.1K |
| Mariner, LLC | 12,193 | $29.0K |
| Sowell Financial Services LLC | 10,400 | $24.8K |
| Crewe Advisors LLC | 3,100 | $7.38K |
| IFP Advisors, Inc | 122 | $290 |
| Rossby Financial, LCC | 2 | $5 |
Not filed for Q4 2025 yet (1)
Institutions that held Jasper Therapeutics, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Qiming U.S. Ventures Management, LLC | 928,964 | $2.21M |